Clinical Trials Directory

Trials / Unknown

UnknownNCT02090790

Comparison of Analgesic Consumption Between Perioperative ıv Dexamethasone and Added to Femoral Block

The Compare the Effect of Peroperative Intravenous Single Dose Dexamethasone and the Addition of Dexamethasone to Femoral Nerve Block on Postoperative Analgesic Consumption Anf Patient Comfort in Unilateral Total Knee Arthroplasty Patients

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
TC Erciyes University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

the aim of this study was to investigate compare the effect of peroperative intravenous single dose dexamethasone and the addition of dexamethasone to femoral nerve block on postoperative analgesic consumption and patient comfort in unilateral total knee arthroplasty patients

Detailed description

Total knee arthroplasty leads to severe postoperative pain. for postoperative pain control after total knee arthroplasty oral -intramuscular opioids ,patient controlled analgesia intravenous or epidural opioids, single -continuous femoral nerve block involving techniques are used. Dexamethasone is a glucocorticoid of high potency and frequently used perioperative.Dexamethasone to the local anaesthetic solution administered trough in femoral nerve blocks significantly prolonged the analgesic effect of the local anaesthetics used on this blocks.If the analgesic efficacy of systemic treatment with dexamethasone is similar with the use of perineural wich is the safest way should be preferred for systemic use.

Conditions

Interventions

TypeNameDescription
DRUGiv dexamethasone2 ml 8 mg iv dexamethasone
DRUGfemoral dexamethasone2ml 8mg dexamethasone administration added 30 ml 0,5 % bupivacain
DRUGserum physiologic2 ml iv serum physiologic

Timeline

Start date
2014-03-01
Primary completion
2014-06-01
Completion
2014-07-01
First posted
2014-03-18
Last updated
2014-03-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02090790. Inclusion in this directory is not an endorsement.